These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 18184372

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice.
    Knobloch M, Konietzko U, Krebs DC, Nitsch RM.
    Neurobiol Aging; 2007 Sep; 28(9):1297-306. PubMed ID: 16876915
    [Abstract] [Full Text] [Related]

  • 5. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
    Hartmann J, Erb C, Ebert U, Baumann KH, Popp A, König G, Klein J.
    Neuroscience; 2004 Sep; 125(4):1009-17. PubMed ID: 15120860
    [Abstract] [Full Text] [Related]

  • 6. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG, Lin YG, Lang DM, Trusko SP, Hirsch JD, Savage MJ, Scott RW, Howland DS.
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
    Bernardo A, Harrison FE, McCord M, Zhao J, Bruchey A, Davies SS, Jackson Roberts L, Mathews PM, Matsuoka Y, Ariga T, Yu RK, Thompson R, McDonald MP.
    Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
    Li Q, Gordon M, Etienne MA, Hammer RP, Morgan D.
    Cell Transplant; 2008 Nov; 17(4):397-408. PubMed ID: 18522242
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes.
    Hermann D, Both M, Ebert U, Gross G, Schoemaker H, Draguhn A, Wicke K, Nimmrich V.
    Neuroscience; 2009 Sep 15; 162(4):1081-90. PubMed ID: 19477243
    [Abstract] [Full Text] [Related]

  • 17. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice.
    Boncristiano S, Calhoun ME, Howard V, Bondolfi L, Kaeser SA, Wiederhold KH, Staufenbiel M, Jucker M.
    Neurobiol Aging; 2005 May 15; 26(5):607-13. PubMed ID: 15708435
    [Abstract] [Full Text] [Related]

  • 18. Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis.
    Mueggler T, Meyer-Luehmann M, Rausch M, Staufenbiel M, Jucker M, Rudin M.
    Eur J Neurosci; 2004 Aug 15; 20(3):811-7. PubMed ID: 15255991
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.
    Pacheco-Quinto J, Rodriguez de Turco EB, DeRosa S, Howard A, Cruz-Sanchez F, Sambamurti K, Refolo L, Petanceska S, Pappolla MA.
    Neurobiol Dis; 2006 Jun 15; 22(3):651-6. PubMed ID: 16516482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.